首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Development of fluorometric reactive oxygen species assay for photosafety evaluation
【24h】

Development of fluorometric reactive oxygen species assay for photosafety evaluation

机译:用于光安全性评估的荧光活性氧种类测定方法的开发

获取原文
获取原文并翻译 | 示例
           

摘要

The present investigation involved an attempt to develop a new reactive oxygen species (ROS) assay system for the photosafety assessment of chemicals using 1,3-diphenylisobenzofuran (DPBF), a fluorescent probe for monitoring ROS generation. The assay conditions of the fluorometric ROS (fROS) assay were optimized focusing on the solvent system, concentration of DPBF, fluorescent determination, screening run time and reproducibility. The photoreactivity of 21 phototoxic and 11 non-phototoxic compounds was assessed by fROS assay, and the obtained ROS data were compared with the results from a micellar ROS (mROS) assay and in vitro/in vivo phototoxicity information to confirm the predictive capacity of the fROS assay. In the optimized fROS assay, intra-day and inter-day precision levels (coefficient of variation) were found to be below 5%, and the Z'-factor for DPBF fluorescence quenching showed a large separation between positive and negative controls. Of all tested compounds, 3 false positive and 7 false negative predictions were observed in the fROS assay, and the negative predictivity for the fROS assay was found to be lower than that for the mROS assay. Although the fROS assay has some limitations, the procedures for it were highly simplified with a marked reduction in screening run time and one analytical sample for monitoring ROS generation from compounds. The fROS assay has the potential to become a new tool for photosafety assessment at an early stage of product development. (C) 2016 Elsevier Ltd. All rights reserved.
机译:本研究涉及尝试开发一种新的活性氧(ROS)测定系统,该系统使用1,3-二苯基异苯并呋喃(DPBF)(一种用于监视ROS生成的荧光探针)对光化学安全性进行评估。荧光ROS(fROS)分析的分析条件已优化,重点是溶剂系统,DPBF浓度,荧光测定,筛选运行时间和重现性。通过fROS分析评估了21种光毒性化合物和11种非光毒性化合物的光反应性,并将获得的ROS数据与胶束ROS(mROS)分析的结果以及体内/体外光毒性信息进行比较,以确认该化合物的预测能力fROS测定。在优化的fROS分析中,发现日内和日间精度水平(变异系数)低于5%,DPBF荧光猝灭的Z'因子显示阳性对照和阴性对照之间存在较大的分离。在所有测试的化合物中,在fROS测定中观察到3个假阳性预测和7个假阴性预测,并且发现fROS测定的阴性预测性低于mROS测定的阴性预测性。尽管fROS测定法有一定的局限性,但其操作程序已大大简化,显着减少了筛选时间,并提供了一种用于监测化合物中ROS生成的分析样品。 fROS测定法有可能在产品开发的早期阶段成为进行光安全性评估的新工具。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号